日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sex differences in risk factors for end-stage kidney disease and death in type 2 diabetes: A retrospective cohort study

2型糖尿病患者终末期肾病和死亡风险因素的性别差异：一项回顾性队列研究

期刊:Journal of Diabetes
影响因子:3.7
doi:10.1111/1753-0407.13367
Oshima, Megumi; Iwata, Yasunori; Toyama, Tadashi; Kitajima, Shinji; Hara, Akinori; Sakai, Norihiko; Shimizu, Miho; Furuichi, Kengo; Haneda, Masakazu; Babazono, Tetsuya; Yokoyama, Hiroki; Iseki, Kunitoshi; Araki, Shinichi; Ninomiya, Toshiharu; Hara, Shigeko; Suzuki, Yoshiki; Iwano, Masayuki; Kusano, Eiji; Moriya, Tatsumi; Satoh, Hiroaki; Nakamura, Hiroyuki; Makino, Hirofumi; Wada, Takashi
糖尿病
代谢
发表日期：2023
文献求助 收藏

Clinical practice of diabetic foot, nephropathy, and retinopathy in Japan: cross-sectional study using local and nationwide questionnaire surveys

日本糖尿病足、肾病和视网膜病变的临床实践：基于地方和全国问卷调查的横断面研究

期刊:Diabetology International
影响因子:1.2
doi:10.1007/s13340-021-00559-6
Fujita, Yukihiro; Haneda, Masakazu
糖尿病
视网膜病变
神经科学
代谢
发表日期：2022
文献求助 收藏

Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes

2型糖尿病患者尿白蛋白和肾功能的综合变化及其导致肾衰竭的风险

期刊:Bmj Open Diabetes Research & Care
影响因子:4.1
doi:10.1136/bmjdrc-2021-002311
Oshima, Megumi; Toyama, Tadashi; Hara, Akinori; Shimizu, Miho; Kitajima, Shinji; Iwata, Yasunori; Sakai, Norihiko; Furuichi, Kengo; Haneda, Masakazu; Babazono, Tetsuya; Yokoyama, Hiroki; Iseki, Kunitoshi; Araki, Shin-Ichi; Ninomiya, Toshiharu; Hara, Shigeko; Suzuki, Yoshiki; Iwano, Masayuki; Kusano, Eiji; Moriya, Tatsumi; Satoh, Hiroaki; Nakamura, Hiroyuki; Makino, Hirofumi; Wada, Takashi
糖尿病
代谢
发表日期：2021
文献求助 收藏

Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)

针对晚期糖尿病肾病患者的强化多因素干预的随机试验：日本糖尿病肾病缓解和消退团队试验（DNETT-Japan）

期刊:Journal of Diabetes Investigation
影响因子:3
doi:10.1111/jdi.13339
Shikata, Kenichi; Haneda, Masakazu; Ninomiya, Toshiharu; Koya, Daisuke; Suzuki, Yoshiki; Suzuki, Daisuke; Ishida, Hitoshi; Akai, Hiroaki; Tomino, Yasuhiko; Uzu, Takashi; Nishimura, Motonobu; Maeda, Shiro; Ogawa, Daisuke; Miyamoto, Satoshi; Makino, Hirofumi
糖尿病
糖尿病肾病
代谢
发表日期：2021
文献求助 收藏

Extracellular RNA transfer from non-malignant human cholangiocytes can promote cholangiocarcinoma growth

来自非恶性人类胆管细胞的细胞外RNA转移可促进胆管癌的生长

期刊:FEBS Open Bio
影响因子:2.3
doi:10.1002/2211-5463.13294
Ota, Yu; Takahashi, Kenji; Otake, Shin; Tamaki, Yosui; Okada, Mitsuyoshi; Yan, Irene; Aso, Kazunobu; Fujii, Satoshi; Patel, Tushar; Haneda, Masakazu
细胞生物学
肿瘤
胆管癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer

循环中细胞外囊泡包裹的HULC是人类胰腺癌的潜在生物标志物。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.14232
Takahashi, Kenji; Ota, Yu; Kogure, Takayuki; Suzuki, Yuko; Iwamoto, Hidetaka; Yamakita, Keisuke; Kitano, Yohei; Fujii, Satoshi; Haneda, Masakazu; Patel, Tushar; Ota, Tsuguhito
肿瘤
肿瘤免疫
细胞生物学
囊泡
胰腺癌
发表日期：2020
文献求助 收藏

Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan

替格列汀的长期真实世界安全性和有效性：一项在日本开展的超过10,000名2型糖尿病患者的上市后监测研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-019-01189-w
Kadowaki, Takashi; Haneda, Masakazu; Ito, Hiroshi; Sasaki, Kazuyo; Matsukawa, Miyuki; Yamada, Yuka
糖尿病
代谢
发表日期：2020
文献求助 收藏

Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan

替格列汀治疗老年2型糖尿病患者的长期安全性和有效性：日本3年上市后监测的亚组分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-020-01306-0
Kadowaki, Takashi; Haneda, Masakazu; Ito, Hiroshi; Sasaki, Kazuyo; Yamada, Yuka
糖尿病
代谢
发表日期：2020
文献求助 收藏

Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV

前瞻性研究：日本糖尿病合并慢性肢体缺血（Fontaine IV期）患者的临床特征

期刊:Diabetology International
影响因子:1.2
doi:10.1007/s13340-019-00399-5
Takahara, Mitsuyoshi; Okuno, Shota; Nakamura, Izumi; Iida, Osamu; Tsujimura, Takuya; Hata, Yosuke; Fujita, Yukihiro; Haneda, Masakazu
糖尿病
代谢
发表日期：2020
文献求助 收藏

Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial

利格列汀作为恩格列净固定剂量复方制剂的附加药物，用于治疗日本2型糖尿病患者：一项分为两部分、随机、安慰剂对照试验的血糖控制疗效和安全性分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.13496
Kaku, Kohei; Haneda, Masakazu; Tanaka, Yuko; Lee, Ganghyuck; Shiki, Kosuke; Miyamoto, Yuki; Solimando, Fernando; Lee, Jisoo; Lee, Christopher; George, Jyothis
糖尿病
代谢
发表日期：2019
文献求助 收藏